Related Experiment Videos
Current management of gestational trophoblastic neoplasia
Donald Peter Goldstein1, Ross S Berkowitz
1Division of Gynecologic Oncology, New England Trophoblastic Disease Center, Dana Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA 02115, USA. dgoldstein@partners.org
Abstract:
Gestational trophoblastic neoplasms are malignant lesions that arise from placental villous and extravillous trophoblast. Four clinicopathologic conditions make up this entity: invasive mole (IM), choriocarcinoma (CCA), placental-site trophoblastic tumor (PSTT), and epithelioid trophoblastic tumor (ETT). IM and CCA, which make up the majority of these tumors, are highly responsive to chemotherapy with an overall cure rate exceeding 90%, making it usually possible to achieve cure while preserving reproductive function. PSTT and ETT, which rarely occur, are relatively resistant to chemotherapy, making surgery the primary treatment modality, chemotherapy being used only when the disease has metastasized.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Mitral Valve Prolapse III: Nursing Management
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Ovarian Cycle